<- Go Home

Lattice Biologics Ltd.

Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologics products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops acellular demineralized bone scaffold, a human cortical bone demineralized that are used in various applications in orthopedic, neurological, trauma, oral/maxillofacial, and reconstructive procedures; and acellular dermal matrix that provides a natural collagen tissue scaffold that promotes cellular ingrowth, tissue vascularization, and regeneration The company also develops amniotic fluid-based products, such as AmnioBoost and AmnioBlast. In addition, it sells traditional allografts for multi-disciplinary applications, including orthopedics, neurology, podiatry, and oral/maxillofacial. The company is headquartered in Belgrade, Montana.

Market Cap

$128.00

Volume

48.8K

Cash and Equivalents

N/A

EBITDA

-$264.7K

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$645.6K

Profit Margin

41.44%

52 Week High

$0.00

52 Week Low

$0.00

Dividend

N/A

Price / Book Value

0.00

Price / Earnings

-0.00

Price / Tangible Book Value

-0.00

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

-$615.7K

Return on Equity

28.30%

Return on Assets

-24.95

Cash and Short Term Investments

N/A

Debt

N/A

Equity

$100.7K

Revenue

$1.6M

Unlevered FCF

N/A

Sector

Biotechnology

Category

N/A

Company Stock Pitches